1821 – 1830 of 2181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T -> C promoter mutation in non-erythroid tissues
(
- Contribution to journal › Article
-
Mark
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
(
- Contribution to journal › Article
-
Mark
Anticoagulant factor V and thrombosis risk
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
(
- Contribution to journal › Article
-
Mark
Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation
(
- Contribution to journal › Article
-
Mark
Functional characterization of Factor V-Ile359Thr, a novel mutation associated with thrombosis.
(
- Contribution to journal › Article
-
Mark
Economic evaluation: what are we looking for and how do we get there?
(
- Contribution to journal › Article
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
(
- Contribution to journal › Article
-
Mark
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
(
- Contribution to journal › Article
-
Mark
Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
(
- Contribution to journal › Article